Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vaxsafe IB is a live attenuated viral vaccine used in poultry to prevent Infectious Bronchitis (IB), a highly contagious respiratory disease caused by the Infectious Bronchitis Virus (IBV), which is a coronavirus. The active ingredient of Vaxsafe IB is viable, live attenuated strains of the Infectious Bronchitis Virus. The vaccine works by stimulating both local and systemic immunity in chickens, providing protection against clinical disease and reducing economic losses associated with IB outbreaks. It is typically administered via mass application methods such as spray or drinking water to flocks[2]. The product is developed for use in poultry only and has no reported zoonotic potential[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Infectious bronchitis virus vaccine (Vaxsafe IB).